EirGen Pharma is a pharmaceutical company based in Waterford, Ireland. Using its purpose built high containment facility; the company specialises in the development, registration and manufacture of high potency solid dose products for global markets.
EirGen Pharma offers a unique range of pharmaceutical development services for new active substances, generics and upgrades of existing formulations. Our state of the art GMP high containment facility is equipped to develop and manufacture solid dosage forms using innovative isolation technology to allow handling of high potency or moisture sensitive products in an environment which is safe to both the user and the product. Our facility is ideally situated in the south east of Ireland adjacent to road and rail networks and easy access to Dublin, Cork and Waterford airports.
EirGen Pharma are pleased to announce that their oncology molecule Eir-108 has successfully pasRead More... 2012-09-25 - EirGen Pharma receive approval for Oncology Product Eir-080 in EU
EirGen Pharma are pleased to announce that their oncology molecule Eir-080 has been approved foRead More... 2012-09-20 - EirGen Pharma successfully completes GMP facility inspection by US FDA
EirGen Pharma are pleased to announce that we have successfully completed our biannual FDA GMPRead More...NEWS ARCHIVE